Emerald Advisers, LLC Mirum Pharmaceuticals, Inc. Transaction History
Emerald Advisers, LLC
- $2.53 Billion
- Q2 2025
A detailed history of Emerald Advisers, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 305,766 shares of MIRM stock, worth $19.8 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
305,766Holding current value
$19.8 Million% of portfolio
0.61%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
229Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$440 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$339 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$210 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$179 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$171 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.38B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...